1343349-82-5 Usage
Uses
Used in Pharmaceutical Industry:
1-(1-Methanesulfonylpiperidin-4-yl)ethan-1-one is used as a chemical intermediate for the synthesis of various pharmaceuticals. Its unique structure and reactivity contribute to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 1-(1-Methanesulfonylpiperidin-4-yl)ethan-1-one serves as a building block in the creation of agrochemicals. Its versatility allows for the design of compounds that can be used in pest control and crop protection, enhancing agricultural productivity.
Used in Organic Synthesis:
1-(1-Methanesulfonylpiperidin-4-yl)ethan-1-one is utilized as a key component in organic synthesis due to its reactivity. This enables the production of a wide range of organic compounds for various applications, including the development of new materials and the synthesis of complex organic molecules.
Used in Neurological Disorder Treatment Research:
MSPE has been studied for its potential in the treatment of certain neurological disorders. It is used as a research compound to explore its therapeutic effects and mechanisms of action, with the aim of developing new treatments for neurological conditions.
Used in Drug Development:
As a potential drug candidate, 1-(1-Methanesulfonylpiperidin-4-yl)ethan-1-one is involved in drug development processes. Researchers are investigating its pharmacological properties, safety, and efficacy to determine its suitability as a new therapeutic agent for various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 1343349-82-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,4,3,3,4 and 9 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1343349-82:
(9*1)+(8*3)+(7*4)+(6*3)+(5*3)+(4*4)+(3*9)+(2*8)+(1*2)=155
155 % 10 = 5
So 1343349-82-5 is a valid CAS Registry Number.
1343349-82-5Relevant articles and documents
COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CFTR
-
Paragraph 0292, (2017/08/01)
The present disclosure is directed to disclosed compounds that modulate, e.g., address underlying defects in cellular processing of CFTR activity.
